Wikidata

(Q63340718)

English

The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma

clinical trial

In more languages

Statements

short name
DRBEAT (English)
0 references
title
A Phase 2a Study of the Addition of Temozolomide to a Standard Conditioning Regimen for Autologous Stem Cell Transplantation in Relapsed and Refractory Central Nervous System (CNS) Lymphoma (English)
0 references
start time
14 October 2010
0 references
end time
28 July 2017
0 references
number of participants
11
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63340718&oldid=1857180155"